{"id":"8fd6b387-5e03-47ec-829c-d56d0685ad52","slug":"adam-sachs-vs","name":"Adam Sachs","bioBrief":"Co-founder and CEO of Vicarious Surgical (2014-2024); met co-founder Sammy Khalifa at MIT. Led company through $1.1B SPAC merger with D8 Holdings (October 2021) and public listing (NYSE: RBOT). Company entered going-concern and was delisted March 2024. Raised over $1.1B total but failed to achieve FDA clearance before capital ran out.","nationality":null,"verificationPosture":"verified","aliases":[],"sources":[{"url":"https://www.vicarioussurgical.com/article/vicarious-surgical-inc-and-d8-holdings-corp-announce-definitive-business-combination-agreement","title":"Vicarious Surgical and D8 Holdings Announce Definitive Business Combination Agreement","sourceName":"Vicarious Surgical"},{"url":"https://www.lifesciencemarketresearch.com/videos/adam-sachs-co-founder-ceo-of-vicarious-surgical","title":"Adam Sachs, Co-Founder & CEO of Vicarious Surgical","sourceName":"Life Science Intelligence"}],"reviewStatus":"unreviewed","createdAt":"2026-06-11T04:53:14.718Z","updatedAt":"2026-06-11T04:53:14.718Z","educations":[],"companyRoles":[{"id":"7b0239cc-70ff-4ab8-8b81-6ac321530bd6","personId":"8fd6b387-5e03-47ec-829c-d56d0685ad52","companyId":"9dc45318-fb87-4997-a06d-0b54567c6855","role":"ceo","roleTitle":"Co-founder & CEO","startDate":"2014-01-01T00:00:00.000Z","endDate":"2024-03-01T00:00:00.000Z","currentRole":false,"roleBasis":"verified_secondary","createdAt":"2026-06-11T04:53:14.887Z","company":{"slug":"vicarious-surgical","name":"Vicarious Surgical"}}],"boardRoles":[],"investorRoles":[],"foundings":[{"id":"6c4a7d13-050e-487c-bd2b-234ce8f5f7a8","personId":"8fd6b387-5e03-47ec-829c-d56d0685ad52","companyId":"9dc45318-fb87-4997-a06d-0b54567c6855","foundingDate":"2014-01-01T00:00:00.000Z","cofounderStatus":"cofounder","stillAtCompany":false,"createdAt":"2026-06-11T04:53:15.057Z","company":{"slug":"vicarious-surgical","name":"Vicarious Surgical"}}]}